NeuPath Health Inc

V:NPTH Canada Medical Care Facilities
Market Cap
$18.52 Million
CA$26.60 Million CAD
Market Cap Rank
#26408 Global
#139 in Canada
Share Price
CA$0.47
Change (1 day)
+2.17%
52-Week Range
CA$0.17 - CA$0.56
All Time High
CA$1.10
About

NeuPath Health Inc. provides chronic pain management services in Canada. It operates a network of medical clinics in Ontario and Alberta that offer assessments and rehabilitation services to patients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions. The company also provides workplace health services and independent medical assessments to employers and di… Read more

NeuPath Health Inc (NPTH) - Net Assets

Latest net assets as of September 2025: CA$21.26 Million CAD

Based on the latest financial reports, NeuPath Health Inc (NPTH) has net assets worth CA$21.26 Million CAD as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$45.93 Million) and total liabilities (CA$24.67 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CA$21.26 Million
% of Total Assets 46.29%
Annual Growth Rate 17.0%
5-Year Change -22.42%
10-Year Change N/A
Growth Volatility 75.67

NeuPath Health Inc - Net Assets Trend (2019–2024)

This chart illustrates how NeuPath Health Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for NeuPath Health Inc (2019–2024)

The table below shows the annual net assets of NeuPath Health Inc from 2019 to 2024.

Year Net Assets Change
2024-12-31 CA$21.43 Million -1.86%
2023-12-31 CA$21.84 Million +0.86%
2022-12-31 CA$21.65 Million -16.17%
2021-12-31 CA$25.83 Million -6.49%
2020-12-31 CA$27.62 Million +182.71%
2019-12-31 CA$9.77 Million --

Equity Component Analysis

This analysis shows how different components contribute to NeuPath Health Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 1326700000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Other Components CA$48.15 Million 224.98%
Total Equity CA$21.40 Million 100.00%

NeuPath Health Inc Competitors by Market Cap

The table below lists competitors of NeuPath Health Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in NeuPath Health Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 22,054,000 to 21,404,000, a change of -650,000 (-2.9%).
  • Net loss of 728,000 reduced equity.
  • Share repurchases of 24,000 reduced equity.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CA$-728.00K -3.4%
Share Repurchases CA$24.00K -0.11%
Other Changes CA$102.00K +0.48%
Total Change CA$- -2.95%

Book Value vs Market Value Analysis

This analysis compares NeuPath Health Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.24x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 1.37x to 1.24x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2019-12-31 CA$0.34 CA$0.47 x
2020-12-31 CA$0.66 CA$0.47 x
2021-12-31 CA$0.55 CA$0.47 x
2022-12-31 CA$0.43 CA$0.47 x
2023-12-31 CA$0.39 CA$0.47 x
2024-12-31 CA$0.38 CA$0.47 x

Capital Efficiency Dashboard

This dashboard shows how efficiently NeuPath Health Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -3.40%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -1.00%
  • • Asset Turnover: 1.76x
  • • Equity Multiplier: 1.93x
  • Recent ROE (-3.40%) is above the historical average (-18.03%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2019 -54.34% -10.70% 1.31x 3.89x CA$-6.29 Million
2020 -18.31% -10.62% 1.03x 1.67x CA$-7.82 Million
2021 -12.50% -5.31% 1.19x 1.99x CA$-5.81 Million
2022 -19.12% -6.65% 1.39x 2.07x CA$-6.34 Million
2023 -0.49% -0.16% 1.58x 1.89x CA$-2.31 Million
2024 -3.40% -1.00% 1.76x 1.93x CA$-2.87 Million

Industry Comparison

This section compares NeuPath Health Inc's net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

  • Industry: Medical Care Facilities
  • Average net assets among peers: $233,299,464
  • Average return on equity (ROE) among peers: 4.46%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
NeuPath Health Inc (NPTH) CA$21.26 Million -54.34% 1.16x $16.35 Million
Element Lifestyle Retirement Inc (ELM) $-590.09K 0.00% 0.00x $306.54K
KDA Group Inc (KDA) $3.91 Million 14.35% 4.67x $12.88 Million
Premier Health of America Inc (PHA) $154.00K 0.00% 0.28x $459.41K
WELL Health Technologies Corp (WELL) $929.72 Million 3.51% 0.94x $584.47 Million